Tensive Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 31

Employees

  • Latest Deal Type
  • Debt

  • Latest Deal Amount
  • $23.2M

  • Investors
  • 10

Tensive General Information

Description

Developer of vascularized biodegradable prostheses designed to offer a natural breast reconstruction or augmentation. The company's prostheses use porously implantable based on biodegradable synthetic biomaterials and fabricated with internal micro-channels mimicking the blood-vessels architecture for the treatment of breast cancer, enabling patients to improve their quality of life and avoid recurrent and expensive surgical operations.

Contact Information

Website
www.tensive.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Viale Ortles 22/4
  • 20139 Milan
  • Italy
+39 02
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Viale Ortles 22/4
  • 20139 Milan
  • Italy
+39 02

Tensive Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tensive Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Debt - General 03-Sep-2026 $23.2M Completed Generating Revenue
7. Later Stage VC (Series A) 30-Jan-2025 Completed Generating Revenue
6. Later Stage VC 03-Oct-2023 Completed Generating Revenue
5. Grant 19-Dec-2022 Completed Generating Revenue
4. Accelerator/Incubator 01-Nov-2021 Completed Generating Revenue
3. Grant 31-May-2018 Completed Generating Revenue
2. Early Stage VC 20-May-2016 $2.27M $2.27M Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2012 Completed Startup
To view Tensive’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Tensive Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of vascularized biodegradable prostheses designed to offer a natural breast reconstruction or augmentation. Th
Therapeutic Devices
Milan, Italy
31 As of 2026

Westford, MA
 

Marlborough, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tensive Competitors (4)

One of Tensive’s 4 competitors is Cynosure (Other Devices and Supplies), a Private Equity-Backed company based in Westford, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cynosure (Other Devices and Supplies) Private Equity-Backed Westford, MA
CardioFocus Venture Capital-Backed Marlborough, MA
Motiva Private Equity-Backed Seoul, South Korea
Solta Medical Formerly VC-backed Hayward, CA
To view Tensive’s complete competitors history, request access »

Tensive Patents

Tensive Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020471265-A1 Three-dimensional implantable matrix with reduced foreign body response Active 06-Oct-2020
AU-2020471265-A9 Three-dimensional implantable matrix with reduced foreign body response Active 06-Oct-2020
AU-2020471265-B2 Three-dimensional implantable matrix with reduced foreign body response Active 06-Oct-2020
CA-3197747-A1 Three-dimensional implantable matrix with reduced foreign body response Active 06-Oct-2020
EP-4204029-A1 Three-dimensional implantable matrix with reduced foreign body response Active 06-Oct-2020 A61L27/56
To view Tensive’s complete patent history, request access »

Tensive Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tensive Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Panakes Partners Venture Capital Minority
European Innovation Council Accelerator/Incubator Minority
Fondazione Unimi Accelerator/Incubator
Horizon 2020 Government
You’re viewing 5 of 10 investors. Get the full list »

Tensive FAQs

  • When was Tensive founded?

    Tensive was founded in 2012.

  • Where is Tensive headquartered?

    Tensive is headquartered in Milan, Italy.

  • What is the size of Tensive?

    Tensive has 31 total employees.

  • What industry is Tensive in?

    Tensive’s primary industry is Therapeutic Devices.

  • Is Tensive a private or public company?

    Tensive is a Private company.

  • What is Tensive’s current revenue?

    The current revenue for Tensive is .

  • How much funding has Tensive raised over time?

    Tensive has raised $46.1M.

  • Who are Tensive’s investors?

    , Panakes Partners, European Innovation Council, Fondazione Unimi, and Horizon 2020 are 5 of 10 investors who have invested in Tensive.

  • Who are Tensive’s competitors?

    Cynosure (Other Devices and Supplies), CardioFocus, Motiva, and Solta Medical are competitors of Tensive.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process